LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome.
about
Cysteine and glycine-rich protein 2 (CSRP2) transcript levels correlate with leukemia relapse and leukemia-free survival in adults with B-cell acute lymphoblastic leukemia and normal cytogenetics.DNA methylation transcriptionally regulates the putative tumor cell growth suppressor ZNF677 in non-small cell lung cancersGenetic barcode sequencing for screening altered population dynamics of hematopoietic stem cells transduced with lentivirusThe LMO2 -25 Region Harbours GATA2-Dependent Myeloid Enhancer and RUNX-Dependent T-Lymphoid Repressor Activity.High expression of LMO2 predicts a favorable outcome in adult patients with BCR/ABL negative B-cell acute lymphoblastic leukemia.LMO2 attenuates tumor growth by targeting the Wnt signaling pathway in breast and colorectal cancer.LMO2 Enhances Lamellipodia/Filopodia Formation in Basal-Type Breast Cancer Cells by Mediating ARP3-Profilin1 Interaction.LMO2 promotes tumor cell invasion and metastasis in basal-type breast cancer by altering actin cytoskeleton remodelingLIM-domain-only proteins in cancer.LMO2 at 25 years: a paradigm of chromosomal translocation proteins.Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody.Development of safer gene delivery systems to minimize the risk of insertional mutagenesis-related malignancies: a critical issue for the field of gene therapy.LMO2 (LIM domain only 2) is expressed in a subset of acute myeloid leukaemia and correlates with normal karyotype.Prognostic impact of LIM domain only 2 (LMO2) in chronic myelogenous leukaemia.A comprehensive function analysis of LMO2 in different breast cancer subtypes.Lmo2 expression defines tumor cell identity during T-cell leukemogenesis
P2860
Q33829373-C4B39189-2C2D-46DC-BC88-9778B9CD723CQ35238487-67017AD4-8C4C-4F85-A3B9-3DCAC2D9A048Q35655956-6DC35167-4CD7-437D-93C4-58B893B99B75Q35687910-FCC3D03B-AA7F-48BD-ACDC-201AFA9088F7Q36640231-0703BC23-00DC-416E-A21A-3DD342322F16Q37363897-FA115F47-5B46-4D90-BEC6-5E6B46C3A5A0Q37643251-47DEF075-C7C9-492F-AEEA-B22DA5EBF23BQ37706000-AA4BF04C-9027-47F2-A451-4CE408297952Q38072838-2BBD9DB7-8291-42D1-8F6B-DC8D7E244746Q38537084-2CFB6929-D4B7-4D63-90F5-0D3CD2780480Q39384500-A93040CE-1801-4940-9E4E-AF6F3AF6B54DQ41948139-90BB5BA1-B5EC-400C-9E86-5CF9E0AA52B6Q45847205-FCCAE34C-2EFC-40E5-A197-CB4901DDA1E7Q47952371-AA8148AF-0315-49EE-AA65-FDA77764C3FEQ52366341-90185053-938C-4D37-AEBA-A09EBD9395A9Q58051449-9F005AC0-19D3-4458-979E-0D6A8F57FAEF
P2860
LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
LMO2 expression reflects the d ...... and predicts clinical outcome.
@ast
LMO2 expression reflects the d ...... and predicts clinical outcome.
@en
type
label
LMO2 expression reflects the d ...... and predicts clinical outcome.
@ast
LMO2 expression reflects the d ...... and predicts clinical outcome.
@en
prefLabel
LMO2 expression reflects the d ...... and predicts clinical outcome.
@ast
LMO2 expression reflects the d ...... and predicts clinical outcome.
@en
P2093
P2860
P50
P1433
P1476
LMO2 expression reflects the d ...... and predicts clinical outcome
@en
P2093
Eloy F Robles
Erlend B Smeland
Izidore S Lossos
Jose Roman-Gomez
Maria Angela Aznar
Raquel Malumbres
Vanesa Martin-Palanco
Vicente Fresquet
Xabier Agirre
P2860
P304
P356
10.3324/HAEMATOL.2011.040568
P577
2011-04-01T00:00:00Z